| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.08 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |